A novel blood-saving plan for less-invasive primary total hip replacement.
We conducted a quality improvement program to examine the effect of a blood-saving plan during primary total hip replacement (THR) performed using a nonvascular less invasive approach (LI-THR) and compared the results with historical control subjects. Erythropoietin and tranexamic acid (TA) were administered for selected patients. Analysis of 221 (study group) and 186 (historic group) LI-THRs showed reductions in total blood loss by 20% in a group of 133 patients compared to a control group of 82 patients who did not receive TA. This novel blood plan for LI-THR changed practice, improved quality of care, and allowed all patients to remain blood transfusion free.
Hourlier
Hervé
H
Polyclinique de la Thierache, Service d'Orthopedie, Route de Feron, 59212 Wignehies, France.
Fennema
Peter
P
Liné
Bernhard
B
D019644:Arthroplasty, Replacement, Hip / Q000295:instrumentation / Q000379:methods* / Q000706:statistics & numerical data*; D001803:Blood Transfusion / Q000706:statistics & numerical data*; D015897:Comorbidity; D005260:Female; D005602:France / Q000453:epidemiology; D006622:Hip Prosthesis / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000175:diagnosis* / Q000453:epidemiology*; D015995:Prevalence